Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations

MLA

Elizabeth Faust, et al. “Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations.” Value in Health, vol. 24, Nov. 2021, pp. 1628–33. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b88827a69d3ac14fefea556a3dc11f51&authtype=sso&custid=ns315887.

APA

Elizabeth Faust, Louis P. Garrison, Eric Q. Wu, Ed Pezalla, Michael Recht, Eileen K. Sawyer, Nanxin Li, Adrian Towse, & Hongbo Yang. (2021). Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations. Value in Health, 24, 1628–1633.

Chicago

Elizabeth Faust, Louis P. Garrison, Eric Q. Wu, Ed Pezalla, Michael Recht, Eileen K. Sawyer, Nanxin Li, Adrian Towse, and Hongbo Yang. 2021. “Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations.” Value in Health 24 (November): 1628–33. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b88827a69d3ac14fefea556a3dc11f51&authtype=sso&custid=ns315887.